Commercially available:

• Octreotide (Somatostatin, Growth hormone inibitor)
• Bivalirudin (Anti-thrombotic agent)
• Eptifibatide (Anti-thrombotic agent)

Under development:

• Pramlintide (Amylin analog, Type II diabetes)
• Exenatide (GLP-1 analog, Type II diabetes)
• Desmopressin (Diabetes incipidus)

Finished Products dossiers of these peptides are also under development.

For more information about our existing portfolio and our pipeline products please e-mail us.